Form 4: Acadia Pharmaceuticals CEO Stephen Davis Reports Stock Transactions
SEC Form 4
CEO of Acadia Pharmaceuticals, Stephen Davis, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On April 5, 2024, Stephen Davis, CEO of Acadia Pharmaceuticals, acquired 17,333 and 34,666 shares of common stock through the vesting of restricted stock units.
- On April 8, 2024, Davis disposed of 8,858 shares at an average price of $17.87 and 17,716 shares at an average price of $17.87.
- These sales were mandatory to cover withholding taxes related to the vesting of restricted stock units.
- Following these transactions, Davis directly owns 144,267 shares of Acadia Pharmaceuticals common stock.
- Davis also owns 34,667 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. These filings are monitored by investors to gain insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 04/05/2022 | Grant date for some restricted stock units. |
| 04/05/2023 | First vesting date for some restricted stock units. |
| 04/05/2024 | Acquisition of common stock through vesting of restricted stock units. |
| 04/08/2024 | Disposal of common stock to cover withholding taxes. |
| 04/09/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.